Your browser doesn't support javascript.
loading
Synopsis of Sweet! Mouse Models of Diabetic Kidney Disease.
Heinz-Taheny, Kathleen M; Harlan, Shannon M; Qi, Zhonghua; Heuer, Josef G.
Afiliação
  • Heinz-Taheny KM; 1 Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Harlan SM; 1 Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Qi Z; 1 Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Heuer JG; 1 Eli Lilly and Company, Indianapolis, Indiana, USA.
Toxicol Pathol ; 46(8): 970-975, 2018 12.
Article em En | MEDLINE | ID: mdl-30213245
Diabetes mellitus (types 1 and 2) is the leading cause of glomerular disease and end-stage renal disease in most developed countries, with estimates that one-third of people living with diabetes will develop diabetic kidney disease (DKD). The current standard of care medications slow but do not arrest progression of kidney disease, and therefore, therapy for DKD is a highly unmet medical need for patients. To discover and test novel and durable new therapies, it is necessary to develop animal models of human DKD, which authentically recapitulate the human disease state and provide translatable efficacy to human patients. Here, we review selected mouse models of human DKD, which demonstrate many of the features of type 2 human DKD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefropatias Diabéticas / Modelos Animais de Doenças Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefropatias Diabéticas / Modelos Animais de Doenças Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article